Oregon Cancer
News and information for cancer services throughout Oregon.
-
Recognizing the important contributions of oncology APPs
Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.
-
New division director and deputy director of Hematology and Medical Oncology share a vision
Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.
-
New study aims to fill treatment gap for patients with endometrial cancer
For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.
-
Two trials evaluate new approaches to treating non-Hodgkin and follicular lymphomas
New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.
-
Two new trials enrolling patients with rectal cancer and solid tumors
A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.
-
Promising results of Providence-sponsored trial published in npj Breast Cancer
Final outcomes from a Providence Cancer Institute-sponsored phase Ib trial evaluating pembrolizumab with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic TNBC.
-
Providence researchers contribute to more than 20 studies presented at ASCO Annual Meeting
Researchers from Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, shared their investigations to advance cancer research and treatments at the premier event.
-
Breast cancer survivor, artist gives back to Providence
Portland painter credits the support of Providence providers and creating art for helping her recover and heal from breast cancer and the loss of her mother.
-
Providence cancer experts offer free educational talks
Virtual talks at Providence highlight MRI-guided radiation therapy for treating breast cancer, pancreatic cancer treatments, and sexual health during and after ovarian cancer.
-
Immunotherapies evaluated in new trials for AML, melanoma and solid tumor cancers
New investigator-initiated trial at Providence to evaluate a triple combination of medications for treating melanoma, and two new studies evaluating medication combinations to treat AML.
-
Prestigious grant awarded to Providence researcher
Providence researchers awarded an R21 grant from the National Institutes of Health which provides funding for projects with potential to significantly advance biomedical research.
-
Register for a free, virtual cancer nutrition class
A free virtual online class hosted by Providence Cancer Institute will highlight what to eat during cancer treatments, how to manage side effects and how to speed healing.
-
Get to know Dr. Sasha Stanton: Physician, scientist, first soprano
Physician scientist Sasha Stanton, M.D., Ph.D., shares her career journey to medical oncology and breast cancer research at Providence Cancer Institute.
-
Providence volunteer and cancer survivor offers patients hope and a smile
Cancer survivor Jeff Newell shares his experiences as a volunteer at Providence Cancer Institute and how he uses his own cancer journey to impart hope to others.
-
Three studies highlight the range of our pioneering research
Studies open at Providence Cancer Institute in Oregon for patients with head and neck cancer and patients with breast cancer that has metastasized in the brain.
-
Providence Willamette Falls celebrates opening of new cancer center
World class cancer-care is coming even closer to home for Clackamas County residents. Providence Willamette Falls Medical Center is now serving patients at the Carol Daniel Suzuki Cancer Center.
-
Honoring our physicians on Doctors’ Day
In honor of Doctors' Day on March 30, we recognize the significant contributions of physicians and their commitment to providing the most advanced, highest quality care for our cancer patients.
-
Targeted therapies are the focus of new studies for colorectal and bile duct cancers
New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.
-
Celebrating our oncology social workers
In honor of Social Work Month we recognize the incredible contributions of oncology social workers.
-
Cancer vaccine is focus of breast cancer study at Providence
A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.
-
Loading More...